Section 3 · Administration

Cardioplegia

• Cardioplegia
• 3E08016 Introduction of Recombinant Human-activated Protein C into Heart, Open
• 3E08017 Introduction of Other Thrombolytic into Heart, Open Approach
• 3E080GC Introduction of Other Therapeutic Substance into Heart, Open Approach
• 3E080KZ Introduction of Other Diagnostic Substance into Heart, Open Approach
• 3E080PZ Introduction of Platelet Inhibitor into Heart, Open Approach
• 3E08316 Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous
• 3E08317 Introduction of Other Thrombolytic into Heart, Percutaneous Approach
• 3E083GC Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach
• 3E083KZ Introduction of Other Diagnostic Substance into Heart, Percutaneous Approach
• 3E083PZ Introduction of Platelet Inhibitor into Heart, Percutaneous Approach
• 3E084GC Introduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach